Works by BANKS, PHILLIP L.
Results: 7
Efficacy and Safety of LX9211 for Relief of Diabetic Peripheral Neuropathic Pain (RELIEF-DPN 1): Results of a Double-Blind, Randomized, Placebo-Controlled, Proof-of-Concept Study.
- Published in:
- Diabetes Care, 2024, v. 47, n. 8, p. 1325, doi. 10.2337/dc24-0188
- By:
- Publication type:
- Article
136-LB: Efficacy and Safety of Sotagliflozin (SOTA) in Patients with Type 2 Diabetes (T2D) and Moderate Renal Impairment.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-136-LB
- By:
- Publication type:
- Article
135-LB: Efficacy and Safety of Sotagliflozin (SOTA) in Patients with Type 2 Diabetes (T2D) and Severe Renal Impairment.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-135-LB
- By:
- Publication type:
- Article
1129-P: Effect of Sotagliflozin Added to Insulin Therapy on Beta-Hydroxybutyrate in Patients with Type 1 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1129-P
- By:
- Publication type:
- Article
1103-P: Balancing the Risk of DKA and Severe Hypoglycemia with Sotagliflozin in Adults with Type 1 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1103-P
- By:
- Publication type:
- Article
1102-P: Impact of Treatment with Sotagliflozin on the Incidence of Severe Hypoglycemia in Patients with T1D.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1102-P
- By:
- Publication type:
- Article
1100-P: Efficacy and Safety of Sotagliflozin by Baseline Renal Function in Adults with Type 1 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1100-P
- By:
- Publication type:
- Article